News | March 17, 2023
Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Biocorp will receive an initial milestone payment this year
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Proposed combination enhances Pfizer’s position as a leading company in oncology
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
The company will be submitting the responses to US FDA observations within stipulated timeline
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Subscribe To Our Newsletter & Stay Updated
